Drugs / ARO-HBV
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03365947 | Mar 2018 → Apr 2020 | hepatitis B virus infection | Arrowhead Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ARO-HBV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03365947 ↗ |